38. HIV on the Horizon
Thursday, October 27, 2016: 10:30 AM-12:00 PM
Room: 393-396

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • summarize the state of HIV cure research and potential clinical implications
  • describe the role of long-acting antiviral agents in the prevention and treatment of HIV
  • manage inflammation in patients with HIV

Target Audience: Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Members-in-training, Public health practitioners

Tracks: HIV-STD-TB

Moderators:  Rajesh Gandhi, MD, FIDSA, Massachusetts General Hospital and Ragon Institute and Serena Spudich, MD, Yale University School of Medicine

10:30 AM
Update on Cure Research
John Mellors, MD

11:00 AM
11:30 AM

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-230-L02-P


R. Gandhi, EBSCO: Grant Investigator , Educational grant
Gilead: Grant Investigator , Educational grant
Merck: Grant Investigator , Educational grant
Viiv: Grant Investigator , Educational grant

S. Spudich, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.